4.7 Review

Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders

期刊

PSYCHIATRY RESEARCH
卷 229, 期 1-2, 页码 37-48

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2015.05.036

关键词

Generalized anxiety disorder; Social anxiety disorder; Panic disorder; Posttraumatic stress disorder; Obsessive compulsive disorder; Inflammation; Hypothalamic pituitary adrenal axis

资金

  1. CIHR
  2. Sick Kids Foundation
  3. Centre for Addiction and Mental Health Foundation
  4. Canadian Psychiatric Research Foundation
  5. Canadian Foundation for Innovation
  6. GlaxoSmithKline Inc.
  7. Wyeth Pharmaceuticals
  8. Lundbeck Canada Inc.
  9. Eli Lilly
  10. Organon
  11. AstraZeneca
  12. Janssen-Ortho Inc.
  13. Solvay
  14. Genuine Health
  15. Shire
  16. Bristol-Myers Squibb
  17. Takeda
  18. Pfizer
  19. Roche

向作者/读者索取更多资源

As prevalence of anxiety, posttraumatic stress, and obsessive compulsive disorders continue to rise worldwide, increasing focus has been placed on immune mediated theories in understanding the underlying mechanisms of these disorders. Associations between the dysregulation of the hypothalamic pituitary adrenal (HPA) axis and these disorders have been recognized in the scientific literature, specifically in regard to cortisol levels, as well as changes in pro- and anti-inflammatory cytokines. The present commentary will systematically assess the scientific literature within the past decade in regard to the psychoneuroimmunology of anxiety, posttraumatic stress, and obsessive compulsive disorders. Understanding the mechanisms of these disorders is essential in order to determine efficacious and targeted treatment strategies, which may lead to substantial improvements in overall functioning, as well as significant decreases in societal and economic burden. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据